Weatherhaven Global Resources Provides COVID-19 Infrastructure Solutions Across the Globe

Weatherhaven Global Resources, a Canadian company specializing in the design and manufacture of re-deployable infrastructure solutions has shifted its focus during the COVID-19 crisis towards field hospital solutions to aid domestic and foreign governments. Relying on its long history and proven field hospital and isolation ward product offering, Weatherhaven is operating at the highest volumes in its history to help meet the needs in Canada, South America, the Middle East, and Africa.

Weatherhaven’s new COVID-19 isolation ward solution has already been erected in Chile, Panama, and El Salvador and is currently under construction in Guinea and the United Arab Emirates. In Chile, Weatherhaven will provide five turnkey field hospitals that feature 100-bed medical and ICU wards, staff offices, central corridors, patient and staff ablutions, freshwater and sewage treatment plants, power generation facilities, and basic medical furniture among other equipment. Weatherhaven field hospital solutions are also in use in more than a dozen other countries including Canada, Japan, Brazil, Australia, and the UK.

As one of the world's leading providers of shelter solutions for military and commercial applications, Weatherhaven focuses on remote, highly specialized, and re-deployable shelter systems. The Company provides a full suite of shelter solutions and deployment capabilities, ranging from the collaborative design of customized solutions for customers to engineering, supply chain, production, installation, and aftermarket support services. Headquartered in Coquitlam, British Columbia, Weatherhaven has a global sales and manufacturing presence, with product deployments in more than 95 countries on all seven continents.

Fulcrum Capital Partners partnered with the Weatherhaven management team in 2014 to provide capital to support the continued growth of the Company. The investment was funded by Fulcrum Capital’s Private Equity Fund IV and marks the eleventh platform investment in that fund.